Deyong Xiao

Insilicos (United States)

Papers

1

Total Citations

11

H-Index

1

About

Deyong Xiao is a pioneering researcher at the intersection of artificial intelligence, robotics, and the biology of aging. His work centers on developing automated, AI-driven platforms to accelerate the discovery of therapeutic interventions for age-related diseases. Xiao’s most notable contribution is the creation of a fully autonomous robotics laboratory that identified TNIK inhibition as a potent senomorphic agent—a compound that suppresses the harmful effects of senescent cells without killing them. This breakthrough, published in 2024 and already garnering 11 citations, demonstrates a novel approach to targeting cellular senescence, a central hallmark of aging. By combining machine learning with high-throughput robotic experimentation, Xiao’s methodology enables the rapid prioritization of dual-purpose longevity targets that simultaneously address aging and specific diseases. His work represents a significant leap toward scalable, unbiased drug discovery in geroscience. With his innovative integration of AI and lab automation, Xiao is helping to redefine how researchers identify and validate interventions that could extend healthspan, making him a rising leader in the field of computational longevity research.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
AI-Driven Robotics Laboratory Identifies Pharmacological TNIK Inhibition as a Potent Senomorphic Agent
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Insilicos (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago